|
SNRNP27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.052400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.739000E-03 |
| Normal-vs-Stage2 |
2.886600E-01 |
| Normal-vs-Stage3 |
7.427000E-01 |
| Normal-vs-Stage4 |
8.760400E-01 |
| Stage1-vs-Stage2 |
1.902630E-01 |
| Stage1-vs-Stage3 |
1.377670E-03 |
| Stage1-vs-Stage4 |
2.569800E-01 |
| Stage2-vs-Stage3 |
2.276800E-01 |
| Stage2-vs-Stage4 |
5.503400E-01 |
| Stage3-vs-Stage4 |
9.806800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.797670E-02 |
| Normal-vs-AfricanAmerican |
1.386030E-01 |
| Normal-vs-Asian |
6.851800E-01 |
| Caucasian-vs-AfricanAmerican |
4.121800E-01 |
| Caucasian-vs-Asian |
8.406000E-02 |
| AfricanAmerican-vs-Asian |
2.089200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.783980E-03 |
| Normal-vs-Female |
9.389800E-01 |
| Male-vs-Female |
1.89563999999365E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.098190E-01 |
| Normal-vs-Extreme_Weight |
2.499600E-03 |
| Normal-vs-Obese |
3.095200E-01 |
| Normal-vs-Extreme_Obese |
2.164200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.608200E-01 |
| Normal_Weight-vs-Obese |
4.917800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.725800E-01 |
| Extreme_Weight-vs-Obese |
3.521500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.924400E-01 |
| Obese-vs-Extreme_Obese |
4.036800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.650600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.008980E-01 |
| Normal-vs-Age(61-80Yrs) |
4.678400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.215800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.216100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.019200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.196100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.976100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.847600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.889600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.738650E-03 |
| Normal-VS-Type2 PRCC |
1.119380E-01 |
| Normal-VS-KIRP CIMP |
4.720900E-03 |
| Normal-VS-Unclassified PRCC |
3.353200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.133600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.20650000013623E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
5.963600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.577900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.731000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.041300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.361100E-03 |
| Normal-vs-N1 |
2.154800E-01 |
| Normal-vs-N2 |
6.660600E-01 |
| N0-vs-N1 |
3.920400E-03 |
| N0-vs-N2 |
1.392220E-01 |
| N1-vs-N2 |
7.856800E-01 |
|
|
